Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 199

1.

Hypermetabolic Hurthle Cell Adenoma on 18F-FDG PET/CT.

Hassan A, Riaz S, Asif A.

Mol Imaging Radionucl Ther. 2018 Jun 7;27(2):96-98. doi: 10.4274/mirt.49469.

2.

Disseminated Multi-system Sarcoidosis Mimicking Metastases on 18F-FDG PET/CT.

Makis W, Palayew M, Rush C, Probst S.

Mol Imaging Radionucl Ther. 2018 Jun 7;27(2):91-95. doi: 10.4274/mirt.29200.

3.

A Case of Hypertrophic Pulmonary Osteoarthropathy in Both Upper and Lower Extremities: A Rare Involvement.

Okudan B, Coşkun N, Arıcan P, Şefizade R, Naldöken S.

Mol Imaging Radionucl Ther. 2018 Jun 7;27(2):88-90. doi: 10.4274/mirt.78941.

4.

I-131 Radiation-Induced Myelosuppression in Differentiated Thyroid Cancer Therapy.

Probst S, Abikhzer G, Chaussé G, Tamilia M.

Mol Imaging Radionucl Ther. 2018 Jun 7;27(2):84-87. doi: 10.4274/mirt.59454.

5.

Laryngeal Tuberculosis Mimicking Laryngeal Carcinoma on 18F-FDG PET/CT Imaging.

Cengiz A, Göksel S, Başal Y, Taş Gülen Ş, Döğer F, Yürekli Y.

Mol Imaging Radionucl Ther. 2018 Jun 7;27(2):81-83. doi: 10.4274/mirt.44366.

6.

The Contribution of Fluorine 18F-FDG PET/CT to Lung Cancer Diagnosis, Staging and Treatment Planning.

Budak E, Çok G, Akgün A.

Mol Imaging Radionucl Ther. 2018 Jun 7;27(2):73-80. doi: 10.4274/mirt.53315.

7.

Usefulness of 18F-FDG PET/CT in Cutaneous Melanoma Patients with Negative Sentinel Lymph Nodes and High Clark Levels.

Vural Topuz Ö, Görtan FA, Kaya Döner ZR, Önsel Ç, Sayman HB.

Mol Imaging Radionucl Ther. 2018 Jun 7;27(2):66-72. doi: 10.4274/mirt.70783.

8.

Utility of FDG PET/CT in the Management of Primary Testicular Lymphoma.

Okuyucu K, İnce S, Alagöz E, Ataş E, Arslan N.

Mol Imaging Radionucl Ther. 2018 Jun 7;27(2):61-65. doi: 10.4274/mirt.14227.

9.

Factors That Impact Evaluation of Left Ventricular Systolic Parameters in Myocardial Perfusion Gated SPECT with 16 Frame and 8 Frame Acquisition Models.

Ansari M, Hashemi H, Soltanshahi M, Qutbi M, Azizmohammadi Z, Tabeie F, Javadi H, Jafari E, Barekat M, Assadi M.

Mol Imaging Radionucl Ther. 2018 Jun 7;27(2):55-60. doi: 10.4274/mirt.49368.

10.

Inguinal Endometriosis Visualized on I-131 Whole Body Scan.

Çayır D, Araz M, Apaydın M, Çakal E.

Mol Imaging Radionucl Ther. 2018 Feb 1;27(1):52-54. doi: 10.4274/mirt.77044.

11.

Tc-99m MDP Bone SPECT/CT Findings of a Patient Detected with a New Mutation in LEMD3 Gene: A Case of Osteopoikilosis.

Silov G, Erdoğan Z, Erdoğan M, Özdal A, Gençer H, Akalın T, Karaçavuş S.

Mol Imaging Radionucl Ther. 2018 Feb 1;27(1):48-51. doi: 10.4274/mirt.25743.

12.

Primary Thyroid Lymphoma: External Beam Radiation Therapy Induced Thyroiditis Mimics Residual Disease on Serial 18F-FDG PET/CT Imaging.

Makis W, Ciarallo A, Probst S.

Mol Imaging Radionucl Ther. 2018 Feb 1;27(1):41-47. doi: 10.4274/mirt.07088.

13.

Inflammatory and Ischemic Post Liver Transplant Complications Mimic Malignancy on 18F-FDG PET/CT.

Makis W, Ciarallo A, Probst S.

Mol Imaging Radionucl Ther. 2018 Feb 1;27(1):37-40. doi: 10.4274/mirt.03371.

14.

Unilateral Muscle Artifacts due to Non-compliance During Uptake Phase of 18F-FDG PET/CT in an Oncologic Patient.

Makis W, Hudson EW.

Mol Imaging Radionucl Ther. 2018 Feb 1;27(1):32-36. doi: 10.4274/mirt.02419.

15.

The Contribution of SPECT/CT in the Diagnosis of Stress Fracture of the Proximal Tibia.

Okudan B, Coşkun N, Arıcan P.

Mol Imaging Radionucl Ther. 2018 Feb 1;27(1):29-31. doi: 10.4274/mirt.27247.

16.

Sphenoid Bone Fibrous Dysplasia Detected Incidentally on Bone Scintigraphy by the Contribution of SPECT/CT Hybrid Imaging.

Şan H, Okuyucu K, Öner AO, Emer Ö, Karaçalıoğlu AÖ.

Mol Imaging Radionucl Ther. 2018 Feb 1;27(1):25-28. doi: 10.4274/mirt.93685.

17.

Contribution of 18F-FDG PET/CT to Staging of Head and Neck Malignancies.

Ceylan Y, Ömür Ö, Hatipoğlu F.

Mol Imaging Radionucl Ther. 2018 Feb 1;27(1):19-24. doi: 10.4274/mirt.51423.

18.

Evaluation of PET Scanner Performance in PET/MR and PET/CT Systems: NEMA Tests.

Demir M, Toklu T, Abuqbeitah M, Çetin H, Sezgin HS, Yeyin N, Sönmezoğlu K.

Mol Imaging Radionucl Ther. 2018 Feb 1;27(1):10-18. doi: 10.4274/mirt.97659.

19.

The Role of 18F-FDG PET/CT in Evaluating Elevated Levels of Tumor Markers in Breast Cancer.

Göktaş İ, Cayvarlı H.

Mol Imaging Radionucl Ther. 2018 Feb 1;27(1):3-9. doi: 10.4274/mirt.74436.

20.

The Evolving Role of Nuclear Medicine and Molecular Imaging: Theranostics and Personalized Therapeutic Applications.

Bozkurt MF, Özcan Z.

Mol Imaging Radionucl Ther. 2018 Feb 1;27(1):1-2. doi: 10.4274/mirt.30502. No abstract available.

Supplemental Content

Loading ...
Support Center